Rock Hill, SC (PRWEB) December 05, 2013
Taking OTC Drugs is sometimes a gamble. Even if a side effect is rare, it isn’t so rare to the affected person. The FDA came out and issued a warning about OTC Acetaminophen concerning three serious skin conditions. These symptoms could include: blisters, rash, and even damage to the upper layer of the skin on a widespread basis. The problem is that people don’t know their options when seeking out a remedy at their corner pharmacy.
This is what moved a concerned Physician to create a Free Mobile App called “OTC Plus”. With this ingenious Mobile App, anyone can match their symptoms to an OTC Medication, and see which is the best choice. No more blindly going OTC shopping and taking a health gamble. The “OTC Plus” Mobile App is available for both iPhone/iPad and Android platforms, and is saving lives every day. Within this Free App are also money-saving coupons for many of the OTC Drugs contained in the App.
ACE Innovation Group has loaded this App with an enormous amount of OTC-Medications and their accompanying data. The database is updated on a consistent basis to keep up with the latest OTC entries. The “OTC Plus” Mobile App has been a great aid in preventing people from just passing around OTC medications amongst their family and friends.
The doctor behind this new App is Sandeep Grewal, M.D., and the developer of this new App was Myo Sandar Nwe, BE. Dr. Grewal is Board Certified in Internal Medicine. Dr. Grewal was given an Innovation in Healthcare Award 2013 by The Charlotte Business Journal, who also named him to the Top Forty under Forty List. Dr. Grewal has over 10 years of experience in medicine and technology, and is a Board Member of several reputable hospitals and technology companies. He is also well-known as a noted Author and Inventor.
For complete information on the new money-saving App, visit: The Lifesaving OTC plus Mobile App.
ACE Innovation Group
Attn: Brittany Farrar
744 Arden Lane, #100
Rock Hill, SC 29732
"FDA Warns of Rare Acetaminophen Risk", August 1, 2013, FDA U.S. Food and Drug Administration